0001209191-17-058359.txt : 20171030 0001209191-17-058359.hdr.sgml : 20171030 20171030180152 ACCESSION NUMBER: 0001209191-17-058359 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171026 FILED AS OF DATE: 20171030 DATE AS OF CHANGE: 20171030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dyrness Albert D. CENTRAL INDEX KEY: 0001664801 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37759 FILM NUMBER: 171163552 MAIL ADDRESS: STREET 1: C/O ONCOBIOLOGICS, INC. STREET 2: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncobiologics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-26 0 0001649989 Oncobiologics, Inc. ONS 0001664801 Dyrness Albert D. C/O ONCOBIOLOGICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512 1 0 0 0 Stock Option (Right to Buy) 1.32 2017-10-26 4 A 0 15000 0.00 A 2027-10-26 Common Stock 15000 15000 D 100% of the shares underlying the option shall vest on October 26, 2018, subject to the Reporting Person providing continuous service to the Issuer on such date. /s/ Lawrence Kenyon, Attorney-in-Fact 2017-10-30